US 6797276
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
expired A61KA61K2039/53A61K2039/54
Quick answer
US patent 6797276 (Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55505, A61K2039/55511